{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:08:39Z","timestamp":1789718919841,"version":"4.0.1"},"reference-count":299,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,4,9]],"date-time":"2008-04-09T00:00:00Z","timestamp":1207699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00210-008-0276-9","type":"journal-article","created":{"date-parts":[[2008,4,8]],"date-time":"2008-04-08T09:00:35Z","timestamp":1207645235000},"page":"181-203","source":"Crossref","is-referenced-by-count":103,"title":["Serotonin pharmacology in the gastrointestinal tract: a review"],"prefix":"10.1007","volume":"377","author":[{"given":"D. T.","family":"Beattie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A. M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,9]]},"reference":[{"key":"276_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000087979","volume":"69","author":"M Aapro","year":"2005","unstructured":"Aapro M (2005) 5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment. Oncology 69:97\u2013109","journal-title":"Oncology"},{"key":"276_CR2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/BF01297028","volume":"36","author":"TL Abell","year":"1991","unstructured":"Abell TL, Camilleri M, DiMagno EP, Hench VS, Zinsmeister AR, Malagelada JR (1991) Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 36:616\u2013620","journal-title":"Dig Dis Sci"},{"key":"276_CR3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1073\/pnas.90.2.408","volume":"90","author":"N Adham","year":"1993","unstructured":"Adham N, Kao HT, Schechter LE, Bard J, Olsen M, Urquhart D, Durkin M, Hartig PR, Weinshank RL, Branchek TA (1993) Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc Natl Acad Sci USA 90:408\u2013412","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"276_CR4","first-page":"S36","volume":"141","author":"SPH Alexander","year":"2004","unstructured":"Alexander SPH, Mathie A, Peters JA (2004) Guide to receptors and channels. Br J Pharmacol 141(Suppl 1):S36\u2013S37","journal-title":"Br J Pharmacol"},{"key":"276_CR5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bjc.1995.452","volume":"72","author":"AB Alfieri","year":"1995","unstructured":"Alfieri AB, Cubeddu LX (1995) Comparative efficacy of a single oral dose of ondansetron and of buspirone against cisplatin-induced emesis in cancer patients. Br J Cancer 72:1013\u20131015","journal-title":"Br J Cancer"},{"key":"276_CR6","volume-title":"The burden of gastrointestinal diseases","author":"American Gastroenterological Association","year":"2002","unstructured":"American Gastroenterological Association (2002) The burden of gastrointestinal diseases. American Gastroenterological Association, Bethesda, MD"},{"key":"276_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","volume":"130","author":"W Atkinson","year":"2006","unstructured":"Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA (2006) Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 130:34\u201343","journal-title":"Gastroenterology"},{"key":"276_CR8","first-page":"672","volume":"294","author":"WL Bacon","year":"2000","unstructured":"Bacon WL, Beck SG (2000) 5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther 294:672\u2013679","journal-title":"J Pharmacol Exp Ther"},{"key":"276_CR9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2003.11.019","volume":"484","author":"F Bai","year":"2004","unstructured":"Bai F, Yin T, Johnstone EM, Su C, Varga G, Little SP, Nelson DL (2004) Molecular cloning and pharmacological characterization of the guinea pig 5-HT1E receptor. Eur J Pharmacol 484:127\u2013139","journal-title":"Eur J Pharmacol"},{"key":"276_CR10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ajhp\/62.7.700","volume":"62","author":"DE Baker","year":"2005","unstructured":"Baker DE (2005) Rationale for using serotonergic agents to treat irritable bowel syndrome. Am J Health-Syst Pharm 62:700\u2013711","journal-title":"Am J Health-Syst Pharm"},{"key":"276_CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.clpt.2005.02.002","volume":"77","author":"HL Banh","year":"2005","unstructured":"Banh HL, MacLean C, Topp T, Hall R (2005) The use of tegaserod in critically ill patients with impaired gastric motility. Clin Pharmacol Ther 77:583\u2013586","journal-title":"Clin Pharmacol Ther"},{"key":"276_CR12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1476-5381.1995.tb13263.x","volume":"114","author":"SE Banner","year":"1995","unstructured":"Banner SE, Sanger GJ (1995) Differences between 5-HT3 receptor antagonists in modulation of visceral hypersensitivity. Br J Pharmacol 114:558\u2013562","journal-title":"Br J Pharmacol"},{"key":"276_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/107424840200700202","volume":"7","author":"JT Barbey","year":"2002","unstructured":"Barbey JT, Lazzara R, Zipes DP (2002) Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride. J Cardiovasc Pharmacol Ther 7:65\u201376","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"276_CR14","doi-asserted-by":"crossref","first-page":"23422","DOI":"10.1016\/S0021-9258(19)49479-9","volume":"268","author":"JA Bard","year":"1993","unstructured":"Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL (1993) Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem 268:23422\u201323426","journal-title":"J Biol Chem"},{"key":"276_CR15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083\u20131152","journal-title":"Neuropharmacology"},{"key":"276_CR16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bjp.0705929","volume":"143","author":"DT Beattie","year":"2004","unstructured":"Beattie DT, Smith JA, Marquess D, Vickery RG, Armstrong SR, Pulido-Rios T, McCullough JL, Sandlund C, Richardson C, Mai N, Humphrey PPA (2004) The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br J Pharmacol 143:549\u2013560","journal-title":"Br J Pharmacol"},{"key":"276_CR17","unstructured":"Beattie DT, Armstrong SR, Marquess D, Shaw J, Smith JA, Humphrey PP (2007) The in vivo preclinical profile of TD-5108, a selective, high intrinsic activity 5-HT4 receptor agonist. Digestive Disease Week, Washington, DC, W1228"},{"key":"276_CR18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1113\/jphysiol.2003.051284","volume":"556","author":"JC Beique","year":"2004","unstructured":"Beique JC, Chapin-Pennick EM, Mladenovic L, Andrade R (2004) Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex. J Physiol 556:739\u2013754","journal-title":"J Physiol"},{"key":"276_CR19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1471-4159.2000.740478.x","volume":"74","author":"E Bender","year":"2000","unstructured":"Bender E, Pindon A, Van Oers I, Zhang YB, Gommeren W, Verhasselt P, Jurzak M, Leysen J, Luyten W (2000) Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant. J Neurochem 74:478\u2013489","journal-title":"J Neurochem"},{"key":"276_CR20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/gast.2002.35990","volume":"123","author":"SM Berman","year":"2002","unstructured":"Berman SM, Chang L, Suyenobu B, Derbyshire SW, Stains J, Fitzgerald L, Mandelkern M, Hamm L, Vogt B, Naliboff BD, Mayer EA (2002) Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist alosetron. Gastroenterology 123:969\u2013977","journal-title":"Gastroenterology"},{"key":"276_CR21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0306-4522(00)00363-8","volume":"101","author":"PP Bertrand","year":"2000","unstructured":"Bertrand PP, Kunze WA, Furness JB, Bornstein JC (2000) The terminals of myenteric intrinsic primary afferent neurons of the guinea-pig ileum are excited by 5-hydroxytryptamine acting at 5-hydroxytryptamine-3 receptors. Neuroscience 101:459\u2013469","journal-title":"Neuroscience"},{"key":"276_CR22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/gut.47.5.667","volume":"47","author":"AE Bharucha","year":"2000","unstructured":"Bharucha AE, Camilleri M, Haydock S, Ferber I, Burton D, Cooper S, Tompson D, Fitzpatrick K, Higgins R, Zinsmeister AR (2000) Effects of a serotonin 5-HT4 receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut 47:667\u2013674","journal-title":"Gut"},{"key":"276_CR23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2982.2006.00812.x","volume":"18","author":"GE Boeckxstaens","year":"2006","unstructured":"Boeckxstaens GE, Tytgat GN, Wajs E, Van Nueten L, De Ridder F, Meulemans A, Tack J (2006) The influence of the novel 5-HT1A agonist R137696 on the proximal stomach function in healthy volunteers. Neurogastroenterol Motil 18:919\u2013926","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejphar.2005.03.013","volume":"513","author":"P Bonaventure","year":"2005","unstructured":"Bonaventure P, Nepomuceno D, Miller K, Chen J, Kuei C, Kamme F, Tran DT, Lovenberg TW, Liu C (2005) Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dogs. Eur J Pharmacol 513:181\u2013192","journal-title":"Eur J Pharmacol"},{"key":"276_CR25","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1476-5381.1995.tb14935.x","volume":"114","author":"RA Borman","year":"1995","unstructured":"Borman RA, Burleigh DE (1995) Functional evidence for a 5-HT2B receptor mediating contraction of longitudinal muscle in human small intestine. Br J Pharmacol 114:1525\u20131527","journal-title":"Br J Pharmacol"},{"key":"276_CR26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(96)00466-9","volume":"309","author":"RA Borman","year":"1996","unstructured":"Borman RA, Burleigh DE (1996) Human colonic mucosa possesses a mixed population of 5-HT receptors. Eur J Pharmacol 309:271\u2013274","journal-title":"Eur J Pharmacol"},{"key":"276_CR27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.1997.tb48182.x","volume":"812","author":"RA Borman","year":"1997","unstructured":"Borman RA, Burleigh DE (1997a) 5-HT1D and 5-HT2B receptors mediate contraction of smooth muscle in human small intestine. Ann NY Acad Sci 812:222\u2013223","journal-title":"Ann NY Acad Sci"},{"key":"276_CR28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1749-6632.1997.tb48183.x","volume":"812","author":"RA Borman","year":"1997","unstructured":"Borman RA, Burleigh DE (1997b) Heterogeneity of 5-HT receptors mediating secretion in the human intestine. Ann NY Acad Sci 812:224\u2013225","journal-title":"Ann NY Acad Sci"},{"key":"276_CR29","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjp.0704571","volume":"135","author":"RA Borman","year":"2002","unstructured":"Borman RA, Tilford NS, Harmer DW, Day N, Ellis ES, Sheldrick RL, Carey J, Coleman RA, Baxter GS (2002) 5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro. Br J Pharmacol 135:1144\u20131151","journal-title":"Br J Pharmacol"},{"key":"276_CR30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.44.5.682","volume":"44","author":"EP Bouras","year":"1999","unstructured":"Bouras EP, Camilleri M, Burton DD, McKinzie S (1999) Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut 44:682\u2013686","journal-title":"Gut"},{"key":"276_CR31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pain.2006.10.028","volume":"130","author":"S Bradesi","year":"2007","unstructured":"Bradesi S, Lao L, McLean PG, Winchester WJ, Lee K, Hicks GA, Mayer EA (2007) Dual role of 5-HT3 receptors in a rat model of delayed stress-induced visceral hyperalgesia. Pain 130:56\u201365","journal-title":"Pain"},{"key":"276_CR32","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1523\/JNEUROSCI.08-07-02582.1988","volume":"8","author":"TA Branchek","year":"1988","unstructured":"Branchek TA, Mawe GM, Gershon MD (1988) Characterization and localization of a peripheral neural 5-hydroxytryptamine receptor subtype (5-HT1P) with a selective agonist, 3H-5-hydroxyindalpine. J Neurosci 8:2582\u20132595","journal-title":"J Neurosci"},{"key":"276_CR33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00210-004-0919-4","volume":"369","author":"T Brattelid","year":"2004","unstructured":"Brattelid T, Kvingedal AM, Krobert KA, Andressen KW, Bach T, Hystad ME, Kaumann AJ, Levy FO (2004) Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i). Naunyn Schmiedeberg\u2019s Arch Pharmacol 369:616\u2013628","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"276_CR34","first-page":"121","volume":"329","author":"MR Briejer","year":"1995","unstructured":"Briejer MR, Akkermans LM, Schuurkes JA (1995a) Interactions of serotonin with multiple receptors and neurotransmitters in the guinea-pig isolated colon. Arch Int Pharmacodyn Ther 329:121\u2013133","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"276_CR35","first-page":"631","volume":"47","author":"MR Briejer","year":"1995","unstructured":"Briejer MR, Akkermans LMA, Schuurkes JAJ (1995b) Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility. Pharmacol Rev 47:631\u2013651","journal-title":"Pharmacol Rev"},{"key":"276_CR36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(01)01087-1","volume":"423","author":"MR Briejer","year":"2001","unstructured":"Briejer MR, Bosmans JP, Van Daele P, Jurzak M, Heylen L, Leysen JE, Prins NH, Schuurkes JAJ (2001a) The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol 423:71\u201383","journal-title":"Eur J Pharmacol"},{"key":"276_CR37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2982.2001.00280.x","volume":"13","author":"MR Briejer","year":"2001","unstructured":"Briejer MR, Prins NH, Schuurkes JA (2001b) Effects of the enterokinetic prucalopride (R093877) on colonic motility in fasted dogs. Neurogastroenterol Motil 13:465\u2013472","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2036.2006.02772.x","volume":"23","author":"D Broekaert","year":"2006","unstructured":"Broekaert D, Fischler B, Sifrim D, Janssens J, Tack J (2006) Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment Pharmacol Ther 23:365\u2013370","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.2042-7158.1993.tb05591.x","volume":"45","author":"NJ Brown","year":"1993","unstructured":"Brown NJ, Horton A, Rumsey RD, Read NW (1993) Granisetron and ondansetron: effects on the ileal brake mechanism in the rat. J Pharm Pharmacol 45:521\u2013524","journal-title":"J Pharm Pharmacol"},{"key":"276_CR40","doi-asserted-by":"crossref","unstructured":"Buchheit KH, Buhl T (1994) Stimulant effects of 5-hydroxytryptamine on guinea pig stomach preparations in vitro. Eur J Pharmacol 262:91\u201397","DOI":"10.1016\/0014-2999(94)90031-0"},{"key":"276_CR41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(95)00752-0","volume":"298","author":"MR Budhoo","year":"1996","unstructured":"Budhoo MR, Harris RP, Kellum JM (1996) 5-Hydroxytryptamine-induced Cl- transport is mediated by 5-HT3 and 5-HT4 receptors in the rat distal colon. Eur J Pharmacol 298:137\u2013144","journal-title":"Eur J Pharmacol"},{"key":"276_CR42","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2036.2004.01901.x","volume":"19","author":"EL Calvert","year":"2004","unstructured":"Calvert EL, Whorwell PJ, Houghton LA (2004) Inter-digestive and post-prandial antro-pyloro-duodenal motor activity in humans: effect of 5-hydroxytryptamine agonism. Aliment Pharmacol Ther 19:805\u2013815","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2036.2001.00925.x","volume":"15","author":"M Camilleri","year":"2001","unstructured":"Camilleri M (2001) Review article: tegaserod. Aliment Pharmacol Ther 15:277\u2013289","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(00)02033-X","volume":"355","author":"M Camilleri","year":"2000","unstructured":"Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW (2000) Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet 355:1035\u20131040","journal-title":"Lancet"},{"key":"276_CR45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/gast.2002.34780","volume":"123","author":"M Camilleri","year":"2002","unstructured":"Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE, McKinzie S, Urrutia R (2002) Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 123:425\u2013432","journal-title":"Gastroenterology"},{"key":"276_CR46","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1542-3565(04)00391-X","volume":"2","author":"M Camilleri","year":"2004","unstructured":"Camilleri M, McKinzie S, Fox J, Foxx-Orenstein A, Burton D, Thomforde G, Baxter K, Zinsmeister AR (2004) Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2:895\u2013904","journal-title":"Clin Gastroenterol Hepatol"},{"key":"276_CR47","unstructured":"Camilleri M, Burton D, Vasquez-Roque MI, Ford T, McKinzie S, Zinsmeister AR (2006) Effects of a novel 5-HT4 agonist, ATI-7505, on gastrointestinal and colonic transit in humans. Abstract T2029, Digestive Disease Week, Los Angeles, CA, May 20\u201325"},{"key":"276_CR48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.gastro.2006.11.020","volume":"132","author":"M Camilleri","year":"2007","unstructured":"Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, Smyrk TC, Urrutia R, Aerssens J, Thielemans L, Gohlmann H, Van den Wyngaert I, Coulie B (2007) Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 132:17\u201325","journal-title":"Gastroenterology"},{"key":"276_CR49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/000456320203900605","volume":"39","author":"RS Carling","year":"2002","unstructured":"Carling RS, Degg TJ, Allen KR, Bax ND, Barth JH (2002) Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem 39:577\u2013582","journal-title":"Ann Clin Biochem"},{"key":"276_CR50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-2999(95)00195-Q","volume":"280","author":"D Carter","year":"1995","unstructured":"Carter D, Champney M, Hwang B, Eglen RM (1995) Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea pig isolated ileum. Eur J Pharmacol 280:243\u2013250","journal-title":"Eur J Pharmacol"},{"key":"276_CR51","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1365-2036.2005.02696.x","volume":"22","author":"BD Cash","year":"2005","unstructured":"Cash BD, Chey WD (2005) Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation. Aliment Pharmacol Ther 22:1047\u20131060","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.yjmcc.2005.04.009","volume":"39","author":"L Castro","year":"2005","unstructured":"Castro L, Mialet-Perez J, Guillemeau A, Stillitano F, Zolk O, Eschenhagen T, Lezoualch F, Bochet P, Fischmeister R (2005) Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes. J Mol Cell Cardiol 39:335\u2013344","journal-title":"J Mol Cell Cardiol"},{"key":"276_CR53","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2982.2006.00810.x","volume":"18","author":"S Cellek","year":"2006","unstructured":"Cellek S, John AK, Thangiah R, Dass NB, Bassil AK, Jarvie EM, Lalude O, Vivekanandan S, Sanger GJ (2006) 5-HT4 receptor agonists enhance both cholinergic and nitrergic activities in human isolated colon circular muscle. Neurogastroenterol Motil 18:853\u2013861","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002100000277","volume":"362","author":"D Centurion","year":"2000","unstructured":"Centurion D, Sanchez-Lopez A, Ortiz MI, De Vries P, Saxena PR, Villalon CM (2000) Mediation of 5-HT-induced internal carotid vasodilation in GR127935- and ritanserin-pretreated dogs by 5-HT7 receptors. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 362:169\u2013176","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"276_CR55","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1572-0241.2006.00459.x","volume":"101","author":"L Chang","year":"2006","unstructured":"Chang L, Chey W, Harris L, Olden K, Surawicz C, Schoenfeld P (2006) Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data. Am J Gastroenterol 101:1069\u20131079","journal-title":"Am J Gastroenterol"},{"key":"276_CR56","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1523\/JNEUROSCI.21-16-06348.2001","volume":"21","author":"JJ Chen","year":"2001","unstructured":"Chen JJ, Zhishan L, Pan H, Murphy DL, Tamir H, Koepsell H, Gershon MD (2001) Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter (SERT): abnormal intestinal motility and the expression of cation transporters. J Neurosci 21:6348\u20136361","journal-title":"J Neurosci"},{"key":"276_CR57","first-page":"G433","volume":"275","author":"JX Chen","year":"1998","unstructured":"Chen JX, Pan H, Rowbotham TP, Wade PR, Gershon (1998) Guinea-pig 5-HT transporter: cloning, expression, distribution and function in intestinal sensory reception. Am J Physiol 275:G433\u2013G448","journal-title":"Am J Physiol"},{"key":"276_CR58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/13543784.14.2.185","volume":"14","author":"WD Chey","year":"2005","unstructured":"Chey WD, Cash BD (2005) Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea. Exp Opin Invest Drugs 14:185\u2013193","journal-title":"Exp Opin Invest Drugs"},{"key":"276_CR59","first-page":"G130","volume":"284","author":"HJ Chial","year":"2003","unstructured":"Chial HJ, Camilleri M, Burton D, Thomforde G, Olden KW, Stephens D (2003a) Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol 284:G130\u2013G137","journal-title":"Am J Physiol"},{"key":"276_CR60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1542-3565(03)70038-X","volume":"1","author":"HJ Chial","year":"2003","unstructured":"Chial HJ, Camilleri M, Ferber I, Delgado-Aros S, Burton D, McKinzie S, Zinsmeister AR (2003b) Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clin Gastroenterol Hepatol 1:211\u2013218","journal-title":"Clin Gastroenterol Hepatol"},{"key":"276_CR61","first-page":"910","volume":"55","author":"S Claeysen","year":"1999","unstructured":"Claeysen S, Sebben M, Becamel C, Bockaert J, Dumuis A (1999) Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. Mol Pharmacol 55:910\u2013920","journal-title":"Mol Pharmacol"},{"key":"276_CR62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2982.1999.00148.x","volume":"11","author":"NM Clayton","year":"1999","unstructured":"Clayton NM, Sargent R, Butler A, Gale J, Maxwell MP, Hunt AA, Barrett VJ, Cambridge D, Bountra C, Humphrey PP (1999) The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat. Neurogastroenterol Motil 11:207\u2013217","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR63","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1365-2036.2002.01252.x","volume":"16","author":"CHM Clemens","year":"2002","unstructured":"Clemens CHM, Samson M, Van Berge Henegouwen GP, Fabri M, Smout AJPM (2002) Effect of alosetron on left colonic motility in non-constipated patients with irritable bowel syndrome and healthy volunteers. Aliment Pharmacol Ther 16:993\u20131002","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR64","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","volume":"126","author":"MD Coates","year":"2004","unstructured":"Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Moses PL (2004) Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126:1657\u20131664","journal-title":"Gastroenterology"},{"key":"276_CR65","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2982.2006.00792.x","volume":"18","author":"MD Coates","year":"2006","unstructured":"Coates MD, Johnson AC, Greenwood-Van Meerveld B, Mawe GM (2006) Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse. Neurogastroenterol Motil 18:464\u2013471","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR66","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1476-5381.1992.tb12788.x","volume":"107","author":"TM Cocks","year":"1992","unstructured":"Cocks TM, Arnold PJ (1992) 5-Hydroxytryptamine (5-HT) mediates potent relaxation in the sheep isolated pulmonary vein via activation of 5-HT4 receptors. Br J Pharmacol 107:591\u2013596","journal-title":"Br J Pharmacol"},{"key":"276_CR67","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2036.2003.01449.x","volume":"17","author":"B Coffin","year":"2003","unstructured":"Coffin B, Farmachidi JP, Rueegg P, Bastie A, Bouhassira D (2003) Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects. Aliment Pharmacol Ther 17:577\u2013585","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1572-0241.2004.04097.x","volume":"99","author":"JA Cole","year":"2004","unstructured":"Cole JA, Cook SF, Sands BE, Ajene AN, Miller DP, Walker AM (2004) Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol 99:486\u2013491","journal-title":"Am J Gastroenterol"},{"key":"276_CR69","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1046\/j.1365-2036.2003.01797.x","volume":"18","author":"NS Coleman","year":"2003","unstructured":"Coleman NS, Marciani L, Blackshaw E, Wright J, Parker M, Yano T, Yamazaki S, Chan PQ, Wilde K, Gowland PA, Perkins AC, Spiller RC (2003) Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans. Aliment Pharmacol Ther 18:1039\u20131048","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-1838(97)00075-1","volume":"66","author":"HJ Cooke","year":"1997","unstructured":"Cooke HJ, Sidhu M, Wang YZ (1997) Activation of 5-HT1P receptors on submucosal afferents subsequently triggers VIP neurons and chloride secretion in the guinea pig colon. J Auton Nerv Syst 66:105\u2013110","journal-title":"J Auton Nerv Syst"},{"key":"276_CR71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000070202","volume":"67","author":"G Coremans","year":"2003","unstructured":"Coremans G, Kerstens R, De Pauw M, Stevens M (2003) Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results from a double-blind, placebo-controlled clinical trial. Digestion 67:82\u201389","journal-title":"Digestion"},{"key":"276_CR72","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0306-4522(96)00275-8","volume":"75","author":"M Costa","year":"1996","unstructured":"Costa M, Brookes SJH, Steele PA, Gibbins I, Burcher E, Kandiah CJ (1996) Neurochemical classification of myenteric neurons in the guinea pig ileum. Neuroscience 75:949\u2013967","journal-title":"Neuroscience"},{"key":"276_CR73","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10350-006-0763-3","volume":"50","author":"MM Costedio","year":"2007","unstructured":"Costedio MM, Hyman N, Mawe GM (2007) Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum 50:376\u2013388","journal-title":"Dis Colon Rectum"},{"key":"276_CR74","first-page":"G902","volume":"272","author":"B Coulie","year":"1997","unstructured":"Coulie B, Tack J, Maes B, Geypens B, De Roo M, Janssens J (1997) Sumatriptan, a selective 5-HT1 receptor agonist, induces a lag phase for gastric emptying of liquids in humans. Am J Physiol 272:G902\u2013G908","journal-title":"Am J Physiol"},{"key":"276_CR75","doi-asserted-by":"crossref","unstructured":"Coulie B, Tack J, Sifrim D, Andrioli A, Janssens J (1999) Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am J Physiol 276:G373\u2013377","DOI":"10.1152\/ajpgi.1999.276.2.G373"},{"key":"276_CR76","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/gast.2003.50055","volume":"124","author":"F Creed","year":"2003","unstructured":"Creed F, Fernandes L, Guthrie E, Palmer S, Ratcliffe J, Read N, Rigby C, Thompson D, Tomenson B (2003) The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 124:303\u2013317","journal-title":"Gastroenterology"},{"key":"276_CR77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2982.2003.00389.x","volume":"15","author":"F Cremonini","year":"2003","unstructured":"Cremonini F, Delgado-Aros S, Camilleri M (2003) Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 15:79\u201386","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1476-5381.1995.tb16340.x","volume":"115","author":"T Croci","year":"1995","unstructured":"Croci T, Landi M, Bianchetti A, Manara L (1995) Drug-induced defaecation in rats: role of central 5-HT1A receptors. Br J Pharmacol 115:203\u2013209","journal-title":"Br J Pharmacol"},{"key":"276_CR79","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM199003223221204","volume":"322","author":"LX Cubeddu","year":"1990","unstructured":"Cubeddu LX, Hoffman IS, Fuenmayor NT, Finn AL (1990) Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. New Eng J Med 322:810\u2013816","journal-title":"New Eng J Med"},{"issue":"Suppl S2","key":"276_CR80","first-page":"A5","volume":"130","author":"A Cuenca","year":"2006","unstructured":"Cuenca A, Liu MT, Holick K, Hen R, Gershon MD (2006) Physiological dependence of gastric emptying and intestinal motility on 5-HT4 receptors: analyses in wild-type and 5-HT4 knockout mice. Gastroenterology 130(Suppl S2):A5","journal-title":"Gastroenterology"},{"key":"276_CR81","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/16941","volume":"397","author":"PA Davies","year":"1999","unstructured":"Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF (1999) The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 397:359\u2013363","journal-title":"Nature"},{"key":"276_CR82","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1046\/j.1365-2036.2001.01103.x","volume":"15","author":"L Degen","year":"2001","unstructured":"Degen L, Matzinger D, Merz M, Appel-Dingemanse S, Osborne S, Luchinger S, Bertold R, Maecke H, Beglinger C (2001) Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 15:1745\u20131751","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR83","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-2982.2005.00715.x","volume":"17","author":"L Degen","year":"2005","unstructured":"Degen L, Petrig C, Studer D, Schroller S, Beglinger C (2005) Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 17:821\u2013826","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR84","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00003495-200161030-00001","volume":"61","author":"F Ponti De","year":"2001","unstructured":"De Ponti F, Tonini M (2001) Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs 61:317\u2013332","journal-title":"Drugs"},{"key":"276_CR85","doi-asserted-by":"crossref","first-page":"G96","DOI":"10.1152\/ajpcell.00559.2002","volume":"285","author":"F Ponti De","year":"2003","unstructured":"De Ponti F, Crema F, Moro E, Nardelli G, Frigo G, Crema A (2003) Role of 5-HT1B\/D receptors in canine gastric accommodation: effect of sumatriptan and 5-HT1B\/D receptor antagonists. Am J Physiol 285:G96\u2013G104","journal-title":"Am J Physiol"},{"key":"276_CR86","first-page":"44","volume":"10","author":"M Deruyttere","year":"1987","unstructured":"Deruyttere M, Lepoutre L, Heylen H, Samain H, Pennoit H (1987) Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study. Clin Ther 10:44\u201351","journal-title":"Clin Ther"},{"key":"276_CR87","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/13543784.12.5.805","volume":"12","author":"SA Doggrell","year":"2003","unstructured":"Doggrell SA (2003) The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation. Expert Opin Invest Drugs 12:805\u2013823","journal-title":"Expert Opin Invest Drugs"},{"key":"276_CR88","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00005344-199907000-00014","volume":"34","author":"MD Drici","year":"1999","unstructured":"Drici MD, Ebert SN, Wang WX, Rodriguez I, Liu XK, Whitfield BH, Woosley RL (1999) Comparison of tegaserod (HTF 919) and its main human metabolite with cisapride and erythromycin on cardiac repolarization in the isolated rabbit heart. J Cardiovasc Pharmacol 34:82\u201388","journal-title":"J Cardiovasc Pharmacol"},{"key":"276_CR89","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","volume":"130","author":"DA Drossman","year":"2006","unstructured":"Drossman DA (2006) The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130:1377\u20131390","journal-title":"Gastroenterology"},{"key":"276_CR90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","volume":"3","author":"SP Dunlop","year":"2005","unstructured":"Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, Spiller RC (2005) Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 3:349\u2013357","journal-title":"Clin Gastroenterol Hepatol"},{"key":"276_CR91","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1476-5381.1995.tb13240.x","volume":"114","author":"ES Ellis","year":"1995","unstructured":"Ellis ES, Byrne C, Murphy OE, Tilford NS, Baxter GS (1995) Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein. Br J Pharmacol 114:400\u2013404","journal-title":"Br J Pharmacol"},{"key":"276_CR92","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/gut.42.4.511","volume":"42","author":"AV Emmanuel","year":"1998","unstructured":"Emmanuel AV, Kamm MA, Roy AJ, Antonelli K (1998) Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers. Gut 42:511\u2013516","journal-title":"Gut"},{"key":"276_CR93","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1046\/j.1365-2036.2002.01272.x","volume":"16","author":"AV Emmanuel","year":"2002","unstructured":"Emmanuel AV, Roy AJ, Nicholls TJ, Kamm MA (2002) Prucalopride, a systemic enterokinetic, for the treatment of constipation. Aliment Pharmacol Ther 16:1347\u20131356","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR94","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2460\/ajvr.67.1.95","volume":"67","author":"L Engel","year":"2006","unstructured":"Engel L, Kobel B, Ontsouka EC, Graber HU, Blum JW, Steiner A, Meylan M (2006) Distribution of mRNA coding for 5-hydroxytryptamine receptor subtypes in the intestines of healthy dairy cows and dairy cows with cecal dilatation\u2013dislocation. Am J Vet Res 67:95\u2013101","journal-title":"Am J Vet Res"},{"key":"276_CR95","first-page":"357","volume":"51","author":"V Erspamer","year":"1937","unstructured":"Erspamer V, Vialli M (1937) Ricerche sul secreto delle cellule enterochromaffini. Boll Soc Med Chir Pavia 51:357\u2013363","journal-title":"Boll Soc Med Chir Pavia"},{"key":"276_CR96","first-page":"416","volume":"8","author":"S Evangelista","year":"2007","unstructured":"Evangelista S (2007) Drug evaluation: Pumosetrag for the treatment of irritable bowel syndrome and gastroesophageal reflux disease. Curr Opin Invest Drugs 8:416\u2013422","journal-title":"Curr Opin Invest Drugs"},{"key":"276_CR97","first-page":"CD003960","volume":"1","author":"BW Evans","year":"2004","unstructured":"Evans BW, Clark WK, Moore DJ, Whorwell PJ (2004) Tegaserod for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 1:CD003960","journal-title":"Cochrane Database Syst Rev"},{"key":"276_CR98","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1523\/JNEUROSCI.20-01-00294.2000","volume":"20","author":"E Fiorica-Howells","year":"2000","unstructured":"Fiorica-Howells E, Maroteaux L, Gershon MD (2000) Serotonin and the 5-HT2B receptor in the development of enteric neurones. J Neurosci 20:294\u2013305","journal-title":"J Neurosci"},{"key":"276_CR99","first-page":"G877","volume":"282","author":"E Fiorica-Howells","year":"2002","unstructured":"Fiorica-Howells E, Hen R, Gingrich J, Li Z, Gershon MD (2002) 5-HT2A receptors: location and functional analysis in intestines of wild-type and 5-HT2A knockout mice. Am J Physiol 282:G877\u2013G893","journal-title":"Am J Physiol"},{"key":"276_CR100","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1002\/j.1460-2075.1992.tb05427.x","volume":"11","author":"M Foguet","year":"1992","unstructured":"Foguet M, Hoyer D, Pardo LA, Parekh A, Kluxen FW, Kalkman HO, St\u00fchmer W, L\u00fcbbert H (1992) Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J 11:3481\u20133487","journal-title":"EMBO J"},{"key":"276_CR101","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/gast.1996.v111.pm8898642","volume":"111","author":"AE Foxx-Orenstein","year":"1996","unstructured":"Foxx-Orenstein AE, Kuemmerle JF, Grider JR (1996) Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine. Gastroenterology 111:1281\u20131290","journal-title":"Gastroenterology"},{"key":"276_CR102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00001813-199204000-00001","volume":"3","author":"AJ Freeman","year":"1992","unstructured":"Freeman AJ, Cunningham KT, Tyers MB (1992) Selectivity of 5-HT3 receptor antagonists and anti-emetic mechanisms of action. Anti-Cancer Drugs 3:79\u201385","journal-title":"Anti-Cancer Drugs"},{"key":"276_CR103","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11938-006-0011-x","volume":"9","author":"FK Friedenberg","year":"2006","unstructured":"Friedenberg FK, Parkman HP (2006) Delayed gastric emptying: whom to test, how to test, and what to do. Curr Treat Options Gastroenterol 9:295\u2013304","journal-title":"Curr Treat Options Gastroenterol"},{"key":"276_CR104","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2710.2005.00695.x","volume":"30","author":"T Fujita","year":"2005","unstructured":"Fujita T, Yokota S, Sawada M, Majima M, Ohtani Y, Kumagai Y (2005) Effect of MKC-733, a 5-HT receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study. J Clin Pharm Ther 30:611\u2013622","journal-title":"J Clin Pharm Ther"},{"key":"276_CR105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1476-5381.1994.tb14064.x","volume":"111","author":"JD Gale","year":"1994","unstructured":"Gale JD, Grossman CJ, Whitehead JW, Oxford AW, Bunce KT, Humphrey PP (1994) GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol 111:332\u2013338","journal-title":"Br J Pharmacol"},{"key":"276_CR106","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0166-4328(96)00096-4","volume":"73","author":"JJ Galligan","year":"1996","unstructured":"Galligan JJ (1996) Electrophysiological studies of 5-hydroxytryptamine receptors on enteric neurons. Behav Brain Res 73:199\u2013201","journal-title":"Behav Brain Res"},{"key":"276_CR107","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2982.2002.00363.x","volume":"14","author":"JJ Galligan","year":"2002","unstructured":"Galligan JJ (2002) Ligand-gated ion channels in the enteric nervous system. Neurogastroenterol Motil 14:611\u2013623","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR108","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-1838(00)00130-2","volume":"81","author":"JJ Galligan","year":"2000","unstructured":"Galligan JJ, LePard KJ, Schneider DA, Zhou X (2000) Multiple mechanisms of fast excitatory synaptic transmission in the enteric nervous system. J Auton Nerv Syst 81:97\u2013103","journal-title":"J Auton Nerv Syst"},{"key":"276_CR109","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2982.2003.00428.x","volume":"15","author":"JJ Galligan","year":"2003","unstructured":"Galligan JJ, Pan H, Messori E (2003) Signalling mechanism coupled to 5-hydroxytryptamine4 receptor-mediated facilitation of fast synaptic transmission in the guinea pig ileum myenteric plexus. Neurogastroenterol Motil 15:523\u2013529","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR110","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1572-0241.2006.00650.x","volume":"101","author":"H Gallo-Torres","year":"2006","unstructured":"Gallo-Torres H, Brinker A, Avigan M (2006) Alosetron: ischemic colitis and serious complications of constipation. Am J Gastroenterol 101:1080\u20131083","journal-title":"Am J Gastroenterol"},{"key":"276_CR111","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/j.gastro.2005.08.060","volume":"130","author":"JP Galmiche","year":"2006","unstructured":"Galmiche JP, Clouse RE, B\u00e1lint A, Cook I, Kahrilas PJ, Paterson WG, Smout AJPM (2006) Functional esophageal disorders. Gastroenterol 130:1459\u20131465","journal-title":"Gastroenterol"},{"key":"276_CR112","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/j.1460-2075.1995.tb07280.x","volume":"14","author":"C Gerald","year":"1995","unstructured":"Gerald C, Adham N, Kao HT, Olsen MA, Laz TM, Schechter LE, Bard JA, Vaysse PJJ, Hartig PR (1995) The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J 14:2806\u20132815","journal-title":"EMBO J"},{"key":"276_CR113","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00001574-200003000-00004","volume":"16","author":"MD Gershon","year":"2000","unstructured":"Gershon MD (2000) 5-HT (serotonin) physiology and related drugs. Curr Opin Gastroenterol 16:113\u2013120","journal-title":"Curr Opin Gastroenterol"},{"issue":"Suppl 7","key":"276_CR114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2004.02180.x","volume":"20","author":"MD Gershon","year":"2004","unstructured":"Gershon MD (2004) Review article: serotonin receptors and transporters-roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 20(Suppl 7):3\u201314","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR115","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1097\/01.mcg.0000156403.37240.30","volume":"39","author":"MD Gershon","year":"2005","unstructured":"Gershon MD (2005) Nerves, reflexes, and the enteric nervous system. J Clin Gastroenterol 39:S184\u2013S193","journal-title":"J Clin Gastroenterol"},{"key":"276_CR116","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","volume":"132","author":"MD Gershon","year":"2007","unstructured":"Gershon MD, Tack J (2007) The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterol 132:397\u2013414","journal-title":"Gastroenterol"},{"key":"276_CR117","first-page":"721","volume":"133","author":"L Gerson","year":"2007","unstructured":"Gerson L (2007) Comment. Gastroenterology 133:721\u2013722","journal-title":"Gastroenterology"},{"key":"276_CR118","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/gast.2002.34245","volume":"123","author":"J Glatzle","year":"2002","unstructured":"Glatzle J, Sternini C, Robin C, Zittel TT, Wong H, Reeve JR, Raybould HE (2002) Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 123:217\u2013226","journal-title":"Gastroenterology"},{"key":"276_CR119","unstructured":"Goldberg MR, Wong SL, Ganju J, Li YP, Ballow CH, Kitt MM (2007a) TD-5108, a selective 5-HT4 agonist with high intrinsic activity, shows immediate and sustained prokinetic activity in healthy subjects. Abstract 318363, Digestive Disease Week, Washington, DC, May 19\u201324"},{"key":"276_CR120","unstructured":"Goldberg M, Li YP, Garofalo B, Valmonte A, Kitt M (2007b) TD-5108, a selective 5-HT4 agonist with high intrinsic activity, increases bowel movement frequency and provides significant overall relief in patients with chronic constipation. In: American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course, Philadelphia PA, October 12\u201317"},{"key":"276_CR121","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/gut.35.4.496","volume":"35","author":"DA Gorard","year":"1994","unstructured":"Gorard DA, Libby GW, Farthing MJ (1994) 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut 35:496\u2013500","journal-title":"Gut"},{"key":"276_CR122","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2036.1990.tb00458.x","volume":"4","author":"S Gore","year":"1990","unstructured":"Gore S, Gilmore IT, Haigh CG, Brownless SM, Stockdale H, Morris AI (1990) Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist. Aliment Pharmacol Ther 4:139\u2013144","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR123","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2982.2006.00767.x","volume":"18","author":"B Greenwood-Van Meerveld","year":"2006","unstructured":"Greenwood-Van Meerveld B, Campbell-Dittmeyer K, Johnson AC, Hicks GA (2006a) 5-HT2B receptors do not modulate sensitivity to colonic distension in rats with acute colorectal hypersensitivity. Neurogastroenterol Motil 18:343\u2013345","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR124","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2982.2005.00723.x","volume":"18","author":"B Greenwood-Van Meerveld","year":"2006","unstructured":"Greenwood-Van Meerveld B, Venkova K, Hicks G, Dennis E, Crowell MD (2006b) Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension. Neurogastroenterol Motil 18:76\u201386","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR125","doi-asserted-by":"crossref","first-page":"G768","DOI":"10.1152\/ajpgi.00384.1998","volume":"284","author":"JR Grider","year":"2003","unstructured":"Grider JR (2003a) Reciprocal activity of longitudinal and circular muscle during intestinal peristaltic reflex. Am J Physiol Gastrointest Liver Physiol 284:G768\u2013G775","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"276_CR126","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.103.053512","volume":"307","author":"JR Grider","year":"2003","unstructured":"Grider JR (2003b) Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J Pharmacol Exp Ther 307:460\u2013467","journal-title":"J Pharmacol Exp Ther"},{"key":"276_CR127","first-page":"232","volume":"303","author":"JR Grider","year":"1990","unstructured":"Grider JR, Makhlouf GM (1990) Regulation of the peristaltic reflex by peptides of the myenteric plexus. Arch Int Pharmacodyn Ther 303:232\u2013251","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"276_CR128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00365528509089650","volume":"20","author":"KO Gr\u00f8nstad","year":"1985","unstructured":"Gr\u00f8nstad KO, DeMagistris L, Dahlstrom A, Nilsson O, Price B, Zinner MJ, Jaffe BM, Ahlman H (1985) The effects of vagal nerve stimulation on endoluminal release of serotonin and substance P into the feline small intestine. Scand J Gastroenterol 20:163\u2013169","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 5","key":"276_CR129","doi-asserted-by":"crossref","first-page":"801S","DOI":"10.1002\/j.1550-8528.1995.tb00503.x","volume":"3","author":"K Haga","year":"1995","unstructured":"Haga K, Asano K, Fukuda T, Kobayakawa T (1995) The function of 5-HT3 receptors on colonic transit in rats. Obesity Res 3(Suppl 5):801S\u2013810S","journal-title":"Obesity Res"},{"key":"276_CR130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0006-291X(92)90654-4","volume":"184","author":"MW Hamblin","year":"1992","unstructured":"Hamblin MW, Metcalf MA, McGuffin RW, Karpells S (1992) Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: a homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity. Biochem Biophys Res Commun 184:752\u2013759","journal-title":"Biochem Biophys Res Commun"},{"key":"276_CR131","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0300-9629(97)00085-6","volume":"118","author":"MB Hansen","year":"1997","unstructured":"Hansen MB, Skadhauge E (1997) Signal transduction pathways for serotonin as an intestinal secretagogue. Comp Biochem Physiol A Physiol 118:283\u2013290","journal-title":"Comp Biochem Physiol A Physiol"},{"key":"276_CR132","doi-asserted-by":"crossref","first-page":"1003\u20131005","DOI":"10.1016\/0165-6147(96)30002-3","volume":"17","author":"PR Hartig","year":"1996","unstructured":"Hartig PR, Hoyer D, Humphrey PP, Martin GR (1996) Alignment of receptor nomenclature with the human genome classification of 5-HT1B and 5-HT1D receptor subtypes. Trends Pharmacol Sci 17:1003\u20131005","journal-title":"Trends Pharmacol Sci"},{"key":"276_CR133","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1113\/expphysiol.1988.sp003124","volume":"73","author":"J Hawthorn","year":"1988","unstructured":"Hawthorn J, Ostler KJ, Andrews PL (1988) The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret. Q J Exp Physiol 73:7\u201321","journal-title":"Q J Exp Physiol"},{"key":"276_CR134","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1073\/pnas.0337340100","volume":"100","author":"PB Hedlund","year":"2003","unstructured":"Hedlund PB, Danielson PE, Thomas EA, Slanina K, Carson MJ, Sutcliffe JG (2003) No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc Natl Acad Sci USA 100:1375\u20131380","journal-title":"Proc Natl Acad Sci USA"},{"key":"276_CR135","first-page":"741","volume":"271","author":"SS Hegde","year":"1994","unstructured":"Hegde SS, Moy TM, Perry MR, Loeb M, Eglen RM (1994) Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice. J Pharmacol Exp Ther 271:741\u2013747","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 6","key":"276_CR136","first-page":"9","volume":"18","author":"PJ Hesketh","year":"2004","unstructured":"Hesketh PJ (2004) Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress. Oncology 18(Suppl 6):9\u201314","journal-title":"Oncology"},{"issue":"Suppl 1","key":"276_CR137","first-page":"A","volume":"120","author":"GA Hicks","year":"2001","unstructured":"Hicks GA, Clayton NM, Gaskin PJ, Kirkup AJ, Su X, Joshi S, Friedrich A, Conner HE, Cox B, Grundy D, Gebhart GF, Humphrey PPA (2001) 5-HT4 receptor agonists stimulate small intestinal transit but do not have direct visceral antinociceptive effects in the rat. Gastroenterology 120(Suppl 1):A\u20136","journal-title":"Gastroenterology"},{"key":"276_CR138","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00002826-200603000-00005","volume":"29","author":"C Hofmann","year":"2002","unstructured":"Hofmann C, Penner U, Dorow R, Pertz HH, Jahnichen S, Horowski R, Latte KP, Palla D, Schurad B (2002) Lisuride a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis. Clin Neuropharmacol 29:80\u201386","journal-title":"Clin Neuropharmacol"},{"key":"276_CR139","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/mds.20329","volume":"19","author":"R Horowski","year":"2004","unstructured":"Horowski R, Jahnichen S, Pertz HH (2004) Fibrotic valvular heart disease is not related to chemical class but to biological function: 5-HT2B receptor activation plays crucial role. Mov Disord 19:1523\u20131524","journal-title":"Mov Disord"},{"key":"276_CR140","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1046\/j.1365-2036.1999.00625.x","volume":"13","author":"LA Houghton","year":"1999","unstructured":"Houghton LA, Jackson NA, Whorwell PJ, Cooper SM (1999) 5-HT4 receptor antagonism in irritable bowel syndrome: effect of SB-207266-A on rectal sensitivity and small bowel transit. Aliment Pharmacol Ther 13:1437\u20131444","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR141","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2036.2000.00762.x","volume":"14","author":"LA Houghton","year":"2000","unstructured":"Houghton LA, Foster JM, Whorwell PJ (2000) Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers. Aliment Pharmacol Ther 14:775\u2013782","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR142","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/gut.52.5.663","volume":"52","author":"LA Houghton","year":"2003","unstructured":"Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ, Rimmer MJ (2003) Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 52:663\u2013670","journal-title":"Gut"},{"key":"276_CR143","first-page":"157","volume":"46","author":"D Hoyer","year":"1994","unstructured":"Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157\u2013203","journal-title":"Pharmacol Rev"},{"key":"276_CR144","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","volume":"71","author":"D Hoyer","year":"2002","unstructured":"Hoyer, D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533\u2013554","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl 2","key":"276_CR145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2036.1999.00003.x-i2","volume":"13","author":"PP Humphrey","year":"1999","unstructured":"Humphrey PP, Bountra C, Clayton N, Kozlowski K (1999) Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 13(Suppl 2):31\u201338","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR146","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/bbrc.1996.5921","volume":"230","author":"Y Imada-Shirakata","year":"1997","unstructured":"Imada-Shirakata Y, Kotera T, Ueda S, Okuma M (1997) Serotonin activates electrolyte transport via 5-HT2A receptor in rat colonic crypt cells. Biochem Biophys Res Commun 230:437\u2013441","journal-title":"Biochem Biophys Res Commun"},{"key":"276_CR147","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.lfs.2006.12.025","volume":"80","author":"HR Irving","year":"2007","unstructured":"Irving HR, Tan YY, Tochon-Danguy N, Liu H, Chetty N, Desmond PV, Pouton CW, Coupar IM (2007) Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon. Life Sci 80:1198\u20131205","journal-title":"Life Sci"},{"key":"276_CR148","first-page":"51","volume":"44","author":"T Ishida","year":"1998","unstructured":"Ishida T, Kawashima S, Hirata K, Yokoyama M (1998) Nitric oxide is produced via 5-HT1B and 5-HT2B receptor activation in human coronary artery endothelial cells. Kobe J Med Sci 44:51\u201363","journal-title":"Kobe J Med Sci"},{"key":"276_CR149","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000102962","volume":"75","author":"MG Ismair","year":"2007","unstructured":"Ismair MG, Kullak-Ublick GA, Blakely RD, Fried M, Vavricka SR (2007) Tegaserod inhibits the serotonin transporter SERT. Digestion 75:90\u201395","journal-title":"Digestion"},{"key":"276_CR150","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.CIR.0000139856.20505.57","volume":"110","author":"F Jaffr\u00e9","year":"2004","unstructured":"Jaffr\u00e9 F, Callebert J, Sarre A, Etienne N, Nebigil CG, Launay JM, Maroteaux L, Monassier L (2004) Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation. Circulation 110:969\u2013974","journal-title":"Circulation"},{"key":"276_CR151","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2982.2004.00613.x","volume":"17","author":"AN James","year":"2005","unstructured":"James AN, Ryan JP, Parkman HP (2005) Effects of the selective serotonin reuptake inhibitor, fluoxetine, on regional gastric contractility. Neurogastroenterol Motil 17:76\u201382","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR152","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bjp.0705507","volume":"140","author":"P Janssen","year":"2003","unstructured":"Janssen P, Prins NH, Moreaux B, Meulemans AL, Lefebvre RA (2003) In vivo characterization of 5-HT1A receptor-mediated gastric relaxation in conscious dogs. Br J Pharmacol 140:913\u2013920","journal-title":"Br J Pharmacol"},{"key":"276_CR153","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejphar.2004.03.054","volume":"492","author":"P Janssen","year":"2004","unstructured":"Janssen P, Tack J, Sifrim D, Meulemans AL, Lefebvre RA (2004) Influence of 5-HT1 receptor agonists on feline stomach relaxation. Eur J Pharmacol 492:259\u2013267","journal-title":"Eur J Pharmacol"},{"key":"276_CR154","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.bjp.0701336","volume":"122","author":"JR Jasper","year":"1997","unstructured":"Jasper JR, Kosaka A, To ZP, Chang DJ, Eglen RM (1997) Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b). Br J Pharmacol 122:126\u2013132","journal-title":"Br J Pharmacol"},{"key":"276_CR155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0300-9629(96)00308-8","volume":"118","author":"GM Jensen","year":"1997","unstructured":"Jensen GM, Gronndahl ML, Nielsen CG, Skadhauge E, Olsen JE, Hansen MB (1997) Effect of ondansetron on Salmonella typhimurium-induced net fluid accumulation in the pig jejunum in vivo. Comp Biochem Physiol 118:297\u2013299","journal-title":"Comp Biochem Physiol"},{"key":"276_CR156","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/gast.2000.19461","volume":"119","author":"W Jiang","year":"2000","unstructured":"Jiang W, Kreis ME, Eastwood C, Kirkup AJ, Humphrey PP, Grundy D (2000) 5-HT(3) and histamine H(1) receptors mediate afferent nerve sensitivity to intestinal anaphylaxis in rats. Gastroenterol 119:1267\u20131275","journal-title":"Gastroenterol"},{"key":"276_CR157","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1016\/S0021-9258(18)42612-9","volume":"267","author":"H Jin","year":"1992","unstructured":"Jin H, Oksenberg D, Ashkenazi A, Peroutka SJ, Duncan AMV, Rozmahel R, Yang Y, Mengod G, Palacios JM, O\u2019Dowd BF (1992) Characterization of the human 5-hydroxytryptamine1B receptor. J Biol Chem 267:5735\u20135738","journal-title":"J Biol Chem"},{"key":"276_CR158","first-page":"93","volume":"288","author":"JG Jin","year":"1999","unstructured":"Jin JG, Foxx-Orenstein AE, Grider JR (1999) Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors. J Pharmacol Exp Ther 288:93\u201397","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 7","key":"276_CR159","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2036.2004.02187.x","volume":"20","author":"JF Johanson","year":"2004","unstructured":"Johanson JF (2004) Review article: tegaserod for chronic constipation. Aliment Pharmacol Ther 20(Suppl 7):20\u201324","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0091-3057(01)00745-6","volume":"71","author":"BJ Jones","year":"2002","unstructured":"Jones BJ, Blackburn TP (2002) The medical benefit of 5-HT research. Pharmacol Biochem Behav 71:555\u2013568","journal-title":"Pharmacol Biochem Behav"},{"key":"276_CR161","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1113\/expphysiol.2004.029058","volume":"90","author":"D Jordan","year":"2005","unstructured":"Jordan D (2005) Vagal control of the heart: central serotonergic (5-HT) mechanisms. Exp Physiol 90:175\u2013181","journal-title":"Exp Physiol"},{"key":"276_CR162","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1046\/j.1365-2036.2000.00854.x","volume":"14","author":"PJ Kahrilas","year":"2000","unstructured":"Kahrilas PJ, Quigley EMM, Castell DO, Spechler SJ (2000) The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 14:1503\u20131509","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR163","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000056107","volume":"63","author":"S Kajita","year":"2001","unstructured":"Kajita S, Ito C, Kawamura R, Yasuda S, Isobe Y, Fukushima K (2001) Pharmacological characterization of a novel 5-HT4 receptor agonist, TS-951, in vitro. Pharmacology 63:8\u201316","journal-title":"Pharmacology"},{"key":"276_CR164","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2036.2002.01185.x","volume":"16","author":"MA Kamm","year":"2002","unstructured":"Kamm MA (2002) Review article: the complexity of drug development for irritable bowel syndrome. Aliment Pharmacol Ther 16:343\u2013351","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR165","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pharmthera.2005.12.004","volume":"111","author":"AJ Kaumann","year":"2006","unstructured":"Kaumann AJ, Levy FO (2006) 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther 111:674\u2013706","journal-title":"Pharmacol Ther"},{"key":"276_CR166","doi-asserted-by":"crossref","first-page":"G357","DOI":"10.1152\/ajpcell.1994.267.2.C357","volume":"267","author":"JM Kellum","year":"1994","unstructured":"Kellum JM, Budhoo MR, Siriwardena AK, Smith EP, Jebraili SA (1994) Serotonin induces Cl- secretion in human jejunal mucosa in vitro via a nonneural pathway at a 5-HT4 receptor. Am J Physiol 267:G357\u2013G363","journal-title":"Am J Physiol"},{"key":"276_CR167","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1136\/gut.2004.041657","volume":"53","author":"TOC Kilkens","year":"2004","unstructured":"Kilkens TOC, Honig A, Van Niewenhoven MA, Riedel WJ, Brummer RJM (2004) Acute tryptophan depletion affects brain\u2013gut responses in irritable bowel syndrome patients and controls. Gut 53:1794\u20131800","journal-title":"Gut"},{"key":"276_CR168","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1111\/j.1572-0241.2000.03177.x","volume":"95","author":"DY Kim","year":"2000","unstructured":"Kim DY, Camilleri M (2000) Serotonin: a mediator of the brain\u2013gut connection. Am J Gastroenterol 95:2698\u20132709","journal-title":"Am J Gastroenterol"},{"key":"276_CR169","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cne.903270206","volume":"327","author":"AL Kirchgessner","year":"1993","unstructured":"Kirchgessner AL, Liu MT, Howard MJ, Gershon MD (1993) Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors. J Comp Neurol 327:233\u2013250","journal-title":"J Comp Neurol"},{"key":"276_CR170","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/(SICI)1096-9861(19960115)364:3<439::AID-CNE5>3.0.CO;2-5","volume":"364","author":"AL Kirchgessner","year":"1996","unstructured":"Kirchgessner AL, Liu MT, Raymond JR, Gershon MD (1996) Identification of cells that express 5-hydroxytryptamine 1A receptors in the nervous systems of the bowel and pancreas. J Comp Neurol 364:439\u2013455","journal-title":"J Comp Neurol"},{"key":"276_CR171","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1471-4159.1996.66010047.x","volume":"66","author":"R Kohen","year":"1996","unstructured":"Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW (1996) Cloning, characterization and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem 66:47\u201356","journal-title":"J Neurochem"},{"key":"276_CR172","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1248\/bpb.30.508","volume":"30","author":"T Komada","year":"2007","unstructured":"Komada T, Yano S (2007) Pharmacological characterization of 5-Hydroxytryptamine-receptor subtypes in circular muscle from the rat stomach. Biol Pharm Bull 30:508\u2013513","journal-title":"Biol Pharm Bull"},{"key":"276_CR173","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/gut.46.4.474","volume":"46","author":"CM Kozlowski","year":"2000","unstructured":"Kozlowski CM, Green A, Grundy D, Boissonade FM, Bountra C (2000) The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distension induced depressor response and spinal c-fos expression in the anaesthetised rat. Gut 46:474\u2013480","journal-title":"Gut"},{"key":"276_CR174","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s002100000369","volume":"363","author":"KA Krobert","year":"2001","unstructured":"Krobert KA, Bach T, Syversveen T, Kvingedal AM, Levy FO (2001) The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 363:620\u2013632","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"276_CR175","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/0016-5085(95)90745-9","volume":"109","author":"JF Kuemmerle","year":"1995","unstructured":"Kuemmerle JF, Murthy KS, Grider JR, Martin DC, Makhlouf GM (1995) Coexpression of 5-HT2A and 5-HT4 receptors coupled to distinct signaling pathways in human intestinal muscle cells. Gastroenterology 109:1791\u20131800","journal-title":"Gastroenterology"},{"key":"276_CR176","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1542-3565(03)70039-1","volume":"1","author":"SD Kuiken","year":"2003","unstructured":"Kuiken SD, Tytgat GN, Boeckxstaens GE (2003) The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol 1:219\u2013228","journal-title":"Clin Gastroenterol Hepatol"},{"key":"276_CR177","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2036.2002.01144.x","volume":"16","author":"B Kuo","year":"2002","unstructured":"Kuo B, Camilleri M, Burton D, Viramontes B, McKinzie S, Thomforde G, O\u2019Connor MK, Brinkmann BH (2002) Effects of 5-HT3 antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther 16:225\u2013233","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR178","first-page":"227","volume":"46","author":"JD Kursar","year":"1994","unstructured":"Kursar JD, Nelson DL, Wainscott DB, Baez M (1994) Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor. Mol Pharmacol 46:227\u2013234","journal-title":"Mol Pharmacol"},{"key":"276_CR179","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2982.2002.00344.x","volume":"14","author":"U Ladabaum","year":"2002","unstructured":"Ladabaum U, Glidden D (2002) Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans. Neurogastroenterol Motil 14:395\u2013402","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR180","first-page":"304","volume":"122","author":"R Lea","year":"2002","unstructured":"Lea R, Houghton LA, Whorwell PJ, Whitaker RP (2002) Evidence for increased plasma 5-hydroxytryptamine (5-HT) concentration following meal ingestion in patients with functional dyspepsia (FD) and its relationship to gender and symptoms. Gastroenterology 122:304","journal-title":"Gastroenterology"},{"key":"276_CR181","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2982.2005.00621.x","volume":"17","author":"PG Leclere","year":"2005","unstructured":"Leclere PG, Prins NH, Schuurkes JA, Lefebvre RA (2005) 5-HT4 receptors located on cholinergic nerves in human colon circular muscle. Neurogastroenterol Motil 17:366\u2013375","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR182","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1568007043482598","volume":"3","author":"JE Leysen","year":"2004","unstructured":"Leysen JE (2004) 5-HT(2) receptors. Curr Drug Target CNS Neurol Disord 3:11\u201326","journal-title":"Curr Drug Target CNS Neurol Disord"},{"issue":"4 Suppl 2","key":"276_CR183","first-page":"A87","volume":"128","author":"M Liu","year":"2005","unstructured":"Liu M, Gershon MD (2005b) Slow excitatory (\u20185-HT1P\u2019-like) responses of mouse myenteric neurons to 5-HT: mediation by heterodimers of 5-HT1B\/1D and Drd2 receptors. Gastroenterology 128(4 Suppl 2):A87","journal-title":"Gastroenterology"},{"key":"276_CR184","first-page":"G1148","volume":"289","author":"M Liu","year":"2005","unstructured":"Liu M, Geddis MS, Wen Y, Setlik W, Gershon MD (2005a) Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am J Physiol 289:G1148\u2013G1163","journal-title":"Am J Physiol"},{"key":"276_CR185","doi-asserted-by":"crossref","first-page":"1480\u20131491","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130:1480\u20131491","journal-title":"Gastroenterology"},{"key":"276_CR186","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2036.1991.tb00014.x","volume":"5","author":"AD Mackie","year":"1991","unstructured":"Mackie AD, Ferrington C, Cowan S, Merrick MV, Baird JD, Palmer KR (1991) The effect of renzapride, a novel prokinetic agent, in diabetic gastroparesis. Aliment Pharmacol Ther 5:135\u2013142","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR187","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1126\/science.1718042","volume":"254","author":"AV Maricq","year":"1991","unstructured":"Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D (1991) Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254:432\u2013437","journal-title":"Science"},{"key":"276_CR188","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.phrs.2006.04.005","volume":"54","author":"F Martel","year":"2006","unstructured":"Martel F (2006) Recent advances on the importance of the serotonin transporter SERT in the rat intestine. Pharmacol Res 54:73\u201376","journal-title":"Pharmacol Res"},{"key":"276_CR189","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1124\/jpet.103.049668","volume":"306","author":"F Martel","year":"2003","unstructured":"Martel F, Monteiro R, Lemos C (2003) Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J Pharmacol Exp Ther 306:355\u2013362","journal-title":"J Pharmacol Exp Ther"},{"key":"276_CR190","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1073\/pnas.83.24.9799","volume":"83","author":"GM Mawe","year":"1986","unstructured":"Mawe GM, Branchek TA, Gershon MD (1986) Peripheral neural serotonin receptors: Identification and characterization with specific antagonists and agonists. Proc Natl Acad Sci USA 83:9799\u20139803","journal-title":"Proc Natl Acad Sci USA"},{"key":"276_CR191","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2006.02858.x","volume":"23","author":"GM Mawe","year":"2006","unstructured":"Mawe GM, Coates MD, Moses PL (2006) Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther 23:1067\u20131076","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR192","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1517\/14656566.4.11.2089","volume":"4","author":"EA Mayer","year":"2003","unstructured":"Mayer EA, Bradesi S (2003) Alosetron and irritable bowel syndrome. Exp Opin Pharmacother 4:2089\u20132098","journal-title":"Exp Opin Pharmacother"},{"key":"276_CR193","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.1365-2036.2002.01287.x","volume":"16","author":"EA Mayer","year":"2002","unstructured":"Mayer EA, Berman S, Derbyshire SWG, Suyenobu B, Chang L, Fitzgerald L, Manelkern M, Hamm L, Vogt B, Naliboff BD (2002) The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. Aliment Pharmacol Ther 16:1357\u20131366","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR194","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1073\/pnas.89.12.5517","volume":"89","author":"G McAllister","year":"1992","unstructured":"McAllister G, Charlesworth A, Snodin C, Beer MS, Noble AJ, Middlemiss DN, Iversen LL, Whiting P (1992) Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. Proc Natl Acad Sci USA 89:5517\u20135521","journal-title":"Proc Natl Acad Sci USA"},{"key":"276_CR195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.6004\/jnccn.2007.0005","volume":"5","author":"R McNulty","year":"2007","unstructured":"McNulty R (2007) Are all 5-HT3 receptor antagonists the same? J Natl Comp Cancer Netw 5:35\u201343","journal-title":"J Natl Comp Cancer Netw"},{"key":"276_CR196","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-328X(01)00095-X","volume":"90","author":"AD Medhurst","year":"2001","unstructured":"Medhurst AD, Lezoualch F, Fischmeister R, Middlemiss DN, Sanger GJ (2001) Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR. Brain Res Mol Brain Res 90:125\u2013134","journal-title":"Brain Res Mol Brain Res"},{"key":"276_CR197","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","volume":"93","author":"H Mertz","year":"1998","unstructured":"Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA (1998) Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 93:160\u2013165","journal-title":"Am J Gastroenterol"},{"key":"276_CR198","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/147323000703500613","volume":"35","author":"NL Meyers","year":"2007","unstructured":"Meyers NL, Hickling RI (2007) The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome. J Int Med Res 35:848\u2013866","journal-title":"J Int Med Res"},{"key":"276_CR199","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bjp.0705061","volume":"138","author":"J Mialet","year":"2003","unstructured":"Mialet J, Fischmeister R, Lezoualch F (2003) Characterization of human 5-HT4(d) receptor desensitization in CHO cells. Br J Pharmacol 138:445\u2013452","journal-title":"Br J Pharmacol"},{"key":"276_CR200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(88)90048-9","volume":"149","author":"AK Mir","year":"1988","unstructured":"Mir AK, Hibert M, Tricklebank MD, Middlemiss DN, Kidd EJ, Fozard JR (1988) MDL 72832: a potent and stereoselective ligand at central and peripheral 5-HT1A receptors. Eur J Pharmacol 149:107\u2013120","journal-title":"Eur J Pharmacol"},{"key":"276_CR201","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pharmthera.2005.05.001","volume":"108","author":"ES Mitchell","year":"2005","unstructured":"Mitchell ES, Neumaier JF (2005) 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 108:320\u2013333","journal-title":"Pharmacol Ther"},{"key":"276_CR202","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.neuroscience.2005.05.006","volume":"134","author":"RL Monro","year":"2005","unstructured":"Monro RL, Bornstein JC, Bertrand PP (2005) Slow excitatory post-synaptic potentials in myenteric AH neurons of the guinea pig ileum are reduced by the 5-hydroxytryptamine(7) receptor antagonist SB 269970. Neuroscience 134:975\u2013986","journal-title":"Neuroscience"},{"key":"276_CR203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1254\/jphs.94.73","volume":"94","author":"T Mori","year":"2004","unstructured":"Mori T, Kawano K, Shishikura T (2004) 5-HT3-receptor antagonist inhibits visceral pain differently in chemical and mechanical stimuli in rats. J Pharmacol Sci 94:73\u201376","journal-title":"J Pharmacol Sci"},{"key":"276_CR204","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1472-8206.1994.tb00837.x","volume":"8","author":"O Morteau","year":"1994","unstructured":"Morteau O, Julia V, Eeckhout C, Bueno L (1994) Influence of 5-HT3 receptor antagonists in visceromotor and nociceptive responses to rectal distension before and during experimental colitis in rats. Fundam Clin Pharmacol 8:553\u2013562","journal-title":"Fundam Clin Pharmacol"},{"key":"276_CR205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/gut.28.8.1033","volume":"28","author":"SA Muller-Lissner","year":"1987","unstructured":"Muller-Lissner SA (1987) Treatment of chronic constipation with cisapride and placebo. Gut 28:1033\u20131038","journal-title":"Gut"},{"key":"276_CR206","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1365-2036.2001.01094.x","volume":"15","author":"SA Muller-Lissner","year":"2001","unstructured":"Muller-Lissner SA, Fumagalli I, Bardhan KD, Pace F, Pecher E, Nault B, Ruegg P (2001) Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 15:1655\u20131666","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR207","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF00169167","volume":"353","author":"Y Nagakura","year":"1996","unstructured":"Nagakura Y, Kamato T, Nishida A, Ito H, Yamano M, Miyata K (1996a) Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 353:489\u2013498","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"276_CR208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-2999(96)00403-7","volume":"311","author":"Y Nagakura","year":"1996","unstructured":"Nagakura Y, Naitoh Y, Kamato T, Yamano M, Miyata K (1996b) Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice. Eur J Pharmacol 311:67\u201372","journal-title":"Eur J Pharmacol"},{"key":"276_CR209","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2217\/14796694.2.5.591","volume":"2","author":"RM Navari","year":"2006","unstructured":"Navari RM (2006) Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist. Future Oncol 2:591\u2013602","journal-title":"Future Oncol"},{"key":"276_CR210","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/01.CIR.0000081520.25714.D9","volume":"108","author":"CG Nebigil","year":"2003","unstructured":"Nebigil CG, Maroteaux L (2003) Functional consequences of serotonin\/5-HT2B receptor signaling in heart. Circulation 108:902\u2013908","journal-title":"Circulation"},{"key":"276_CR211","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.050282397","volume":"97","author":"CG Nebigil","year":"2000","unstructured":"Nebigil CG, Launay JM, Hickel P, Tournois C, Maroteaux L (2000) 5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. Proc Natl Acad Sci USA 97:2591\u20132596","journal-title":"Proc Natl Acad Sci USA"},{"key":"276_CR212","first-page":"53","volume":"3","author":"D Nelson","year":"2004","unstructured":"Nelson D (2004) 5-HT5 receptors. Curr Drug Targets 3:53\u201358","journal-title":"Curr Drug Targets"},{"key":"276_CR213","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3940(02)01256-9","volume":"337","author":"R Nicholson","year":"2003","unstructured":"Nicholson R, Small J, Dixon AK, Spanswick D, Lee K (2003) Serotonin receptor mRNA in dorsal root ganglion neurons. Neurosci Lett 337:119\u2013122","journal-title":"Neurosci Lett"},{"key":"276_CR214","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(03)00503-1","volume":"310","author":"B Niesler","year":"2003","unstructured":"Niesler B, Frank B, Kapeller J, Rappold GA (2003) Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 310:101\u2013111","journal-title":"Gene"},{"key":"276_CR215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(99)00114-4","volume":"372","author":"T Nilsson","year":"1999","unstructured":"Nilsson T, Longmore J, Shaw D, Pantev E, Bard JA, Branchek T, Edvinsson L (1999) Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol 372:49\u201356","journal-title":"Eur J Pharmacol"},{"key":"276_CR216","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1440-1681.2004.04015.x","volume":"31","author":"Y Ning","year":"2004","unstructured":"Ning Y, Zhu JX, Chan HC (2004) Regulation of ion transport by 5-hydroxytryptamine in rat colon. Clin Exp Pharmacol Physiol 31:424\u2013428","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"276_CR217","first-page":"G230","volume":"266","author":"H Pan","year":"1994","unstructured":"Pan H, Galligan JJ (1994) 5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons. Am J Physiol 266:G230\u2013G238","journal-title":"Am J Physiol"},{"key":"276_CR218","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1523\/JNEUROSCI.20-09-03295.2000","volume":"20","author":"H Pan","year":"2000","unstructured":"Pan H, Gershon MD (2000) Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J Neurosci 20:3295\u20133309","journal-title":"J Neurosci"},{"key":"276_CR219","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2004.09.055","volume":"127","author":"HP Parkman","year":"2004","unstructured":"Parkman HP, Hasler WL, Fisher RS (2004) American gastroenterological association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127:1592\u20131622","journal-title":"Gastroenterology"},{"key":"276_CR220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(02)00251-3","volume":"326","author":"D Pascual","year":"2002","unstructured":"Pascual D, Alsasua A, Goicoechea C, Martin MI (2002) The involvement of 5-HT3 and 5-HT4 receptors in two models of gastrointestinal transit in mice. Neurosci Lett 326:163\u2013166","journal-title":"Neurosci Lett"},{"key":"276_CR221","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1053\/j.gastro.2007.04.057","volume":"132","author":"PJ Pasricha","year":"2007","unstructured":"Pasricha PJ (2007) Desperately seeking serotonin\u2026a commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Gastroenterology 132:2287\u20132290","journal-title":"Gastroenterology"},{"key":"276_CR222","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(95)00329-0","volume":"70","author":"PA Pierce","year":"1996","unstructured":"Pierce PA, Xie GX, Levine JD, Peroutka SJ (1996) 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience 70:553\u2013559","journal-title":"Neuroscience"},{"key":"276_CR223","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0306-4522(97)00235-2","volume":"81","author":"PA Pierce","year":"1997","unstructured":"Pierce PA, Xie GX, Meuser T, Peroutka SJ (1997) 5-Hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: a polymerase chain reaction study. Neuroscience 81:813\u2013819","journal-title":"Neuroscience"},{"key":"276_CR224","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/mol.61.1.85","volume":"61","author":"A Pindon","year":"2002","unstructured":"Pindon A, Van Hecke G, Van Gompel P, Lesage AS, Leysen JE, Jurzak M (2002) Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai\/o-proteins. Mol Pharmacol 61:85\u201396","journal-title":"Mol Pharmacol"},{"key":"276_CR225","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1046\/j.1365-2036.1999.00629.x","volume":"13","author":"AC Poen","year":"1999","unstructured":"Poen AC, Felt-Bersma RJF, Van Dongen PAM, Meuwissen SGM (1999) Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers. Aliment Pharmacol Ther 13:1493\u20131497","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR226","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1074\/jbc.M106529200","volume":"277","author":"EG Ponimaskin","year":"2002","unstructured":"Ponimaskin EG, Heine M, Joubert L, Sebben M, Bickmeyer U, Richter DW, Dumuis A (2002) The 5-hydroxytryptamine(4a) receptor is palmitoylated at two different sites, and acylation is critically involved in regulation of receptor constitutive activity. J Biol Chem 277:2534\u20132546","journal-title":"J Biol Chem"},{"key":"276_CR227","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00441-006-0181-9","volume":"325","author":"DP Poole","year":"2006","unstructured":"Poole DP, Xu B, Koh SL, Hunne B, Coupar IM, Irving HR, Shinjo K, Furness JB (2006) Identification of neurons that express 5-hydroxytryptamine4 receptors in intestine. Cell Tissue Res 325:413\u2013422","journal-title":"Cell Tissue Res"},{"key":"276_CR228","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0016-5085(00)70251-4","volume":"118","author":"CM Prather","year":"2000","unstructured":"Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G (2000) Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 118:463\u2013468","journal-title":"Gastroenterology"},{"key":"276_CR229","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/sj.bjp.0700954","volume":"120","author":"NH Prins","year":"1997","unstructured":"Prins NH, Briejer MR, Schuurkes JA (1997) Characterization of the contraction to 5-HT in the canine colon longitudinal muscle. Br J Pharmacol 120:714\u2013720","journal-title":"Br J Pharmacol"},{"key":"276_CR230","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.bjp.0702762","volume":"128","author":"NH Prins","year":"1999","unstructured":"Prins NH, Briejer MR, Van Bergen PJ, Akkermans LM, Schuurkes JA (1999a) Evidence for 5-HT7 receptors mediating relaxation of human colonic circular smooth muscle. Br J Pharmacol 128:849\u2013852","journal-title":"Br J Pharmacol"},{"key":"276_CR231","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/sj.bjp.0702665","volume":"127","author":"NH Prins","year":"1999","unstructured":"Prins NH, Van Haselen JF, Lefebvre RA, Briejer MR, Akkermans LM, Schuurkes JA (1999b) Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle. Br J Pharmacol 127:1431\u20131437","journal-title":"Br J Pharmacol"},{"key":"276_CR232","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1073\/pnas.90.6.2542","volume":"90","author":"S Ramamoorthy","year":"1993","unstructured":"Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542\u20132546","journal-title":"Proc Natl Acad Sci USA"},{"key":"276_CR233","first-page":"G367","volume":"284","author":"HE Raybould","year":"2003","unstructured":"Raybould HE, Glatzle J, Robin C, Meyer JH, Phan T, Wong H, Sternini C (2003) Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol 284:G367\u2013G372","journal-title":"Am J Physiol"},{"key":"276_CR234","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0163-7258(94)90009-4","volume":"62","author":"NM Read","year":"1994","unstructured":"Read NM, Gwee KA (1994) The importance of 5-hydroxytryptamine receptors in the gut. Pharmacol Ther 62:159\u2013173","journal-title":"Pharmacol Ther"},{"key":"276_CR235","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1476-5381.1991.tb12301.x","volume":"103","author":"JJ Reeves","year":"1991","unstructured":"Reeves JJ, Bunce KT, Humphrey PP (1991) Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus. Br J Pharmacol 103:1067\u20131072","journal-title":"Br J Pharmacol"},{"key":"276_CR236","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF00170878","volume":"349","author":"CA Rizzi","year":"1994","unstructured":"Rizzi CA, Sagrada A, Schiavone A, Schiantarelli P, Cesana R, Schiavi GB, Ladinsky H, Donetti A (1994) Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 349:338\u2013345","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"276_CR237","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cgh.2006.01.014","volume":"4","author":"S Rodriguez-Stanley","year":"2006","unstructured":"Rodriguez-Stanley S, Zubaidi S, Proskin HM, Kralstein JR, Shetzline MA, Miner PB, Philip B (2006) Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity. Clin Gastroenterol Hepatol 4:442\u2013450","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"276_CR238","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/annonc\/mdj936","volume":"17","author":"F Roila","year":"2006","unstructured":"Roila F, Fatigoni S (2006) New antiemetic drugs. Ann Oncol 17(Suppl 2):96\u2013100","journal-title":"Ann Oncol"},{"key":"276_CR239","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/bbrc.1993.1619","volume":"193","author":"M Ruat","year":"1993","unstructured":"Ruat M, Traiffort E, Arrang JM, Tardivellacombe J, Diaz J, Leurs R, Schwartz JC (1993) A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 193:268\u2013276","journal-title":"Biochem Biophys Res Commun"},{"key":"276_CR240","first-page":"284","volume":"2","author":"EB Rubenstein","year":"2004","unstructured":"Rubenstein EB (2004) Palonosetron: a unique 5-HT(3) receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting. Clin Adv Hematol Oncol 2:284\u2013288","journal-title":"Clin Adv Hematol Oncol"},{"key":"276_CR241","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2036.2006.03005.x","volume":"24","author":"RJ Saad","year":"2006","unstructured":"Saad RJ, Chey WD (2006) Review article: current and emerging therapies for functional dyspepsia. Aliment Pharmacol Ther 24:475\u2013492","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR242","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/00365520600641480","volume":"41","author":"B S\u00e4fsten","year":"2006","unstructured":"S\u00e4fsten B, Sj\u00f6blom M, Flemstr\u00f6m G (2006) Serotonin increases protective duodenal bicarbonate secretion via enteric ganglia and a 5-HT4-dependent pathway. Scand J Gastroenterol 41:1279\u20131289","journal-title":"Scand J Gastroenterol"},{"key":"276_CR243","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-291X(91)92105-S","volume":"181","author":"AG Saltzman","year":"1991","unstructured":"Saltzman AG, Morse B, Whitman MM, Ivanshchenko Y, Jaye M, Felder S (1991) Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. Biochem Biophys Res Commun 181:1469\u20131478","journal-title":"Biochem Biophys Res Commun"},{"key":"276_CR244","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autneu.2006.07.009","volume":"129","author":"GJ Sanger","year":"2006","unstructured":"Sanger GJ, Andrews PLR (2006) Treatment of nausea and vomiting: gaps in our knowledge. Autonom Neurosci Basic Clin 129:3\u201316","journal-title":"Autonom Neurosci Basic Clin"},{"key":"276_CR245","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.2042-7158.1994.tb03879.x","volume":"46","author":"GJ Sanger","year":"1994","unstructured":"Sanger GJ, Wardle KA (1994) Constipation evoked by 5-HT3-receptor antagonism: evidence for heterogeneous efficacy among different antagonists in guinea pigs. J Pharm Pharmacol 46:666\u2013670","journal-title":"J Pharm Pharmacol"},{"key":"276_CR246","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2982.1998.00106.x","volume":"10","author":"GJ Sanger","year":"1998","unstructured":"Sanger GJ, Banner SE, Smith MI, Wardle KA (1998) SB-207266: 5-HT4 receptor antagonism in human isolated gut and prevention of 5-HT-evoked sensitization of peristalsis and increased defaecation in animal models. Neurogastroenterol Motil 10:271\u2013279","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR247","first-page":"387","volume":"252","author":"P Schoeffter","year":"1990","unstructured":"Schoeffter P, Hoyer D (1990) 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. J Pharmacol Exp Ther 252:387\u2013395","journal-title":"J Pharmacol Exp Ther"},{"key":"276_CR248","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/PL00005206","volume":"357","author":"H Schworer","year":"1998","unstructured":"Schworer H, Ramadori G (1998) Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 357:548\u2013552","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"276_CR249","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1016\/S0021-9258(17)46830-X","volume":"268","author":"Y Shen","year":"1993","unstructured":"Shen Y, Monsma FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR (1993) Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 268:18200\u201318204","journal-title":"J Biol Chem"},{"key":"276_CR250","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1111\/j.1572-0241.2006.00811.x","volume":"101","author":"J Shufflebotham","year":"2006","unstructured":"Shufflebotham J, Hood S, Hendry J, Hince DA, Morris K, Nutt D, Probert C, Potokar J (2006) Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome. Am J Gastroenterol 101:2582\u20132587","journal-title":"Am J Gastroenterol"},{"key":"276_CR251","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1111\/j.1572-0241.1999.01509.x","volume":"94","author":"D Sifrim","year":"1999","unstructured":"Sifrim D, Holloway RH, Tack J, Zelter A, Missotten T, Coulie B, Janssens J (1999) Effect of sumatriptan, a 5-HT1 agonist, on the frequency of transient lower esophageal sphincter relaxations and gastroesophageal reflux in healthy subjects. Am J Gastroenterol 94:3158\u20133164","journal-title":"Am J Gastroenterol"},{"key":"276_CR252","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2004.04.034","volume":"494","author":"DV Sivarao","year":"2004","unstructured":"Sivarao DV, Newberry K, Lodge NJ (2004) Effect of the 5-HT1A receptor partial agonist buspirone on colorectal distension-induced pseudoaffective and behavioral responses in the female Wistar rat. Eur J Pharmacol 494:23\u201329","journal-title":"Eur J Pharmacol"},{"key":"276_CR253","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2036.2002.01210.x","volume":"16","author":"CE Sloots","year":"2002","unstructured":"Sloots CE, Poen AC, Kerstens R, Stevens M, De Pauw M, Van Oene JC, Meuwissen SG, Felt-Bersma RJ (2002) Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation. Aliment Pharmacol Ther 16:759\u2013767","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR254","unstructured":"Smith JA, Beattie DT, Cuthbert AW, Ropenga A, Marquess D, Shaw J, Vickery R, Humphrey PP (2007) TD-5108, a selective, high intrinsic activity 5-HT4 receptor agonist - in vitro profile at human recombinant 5-HT4 receptor splice variant and human isolated colon. Digestive Disease Week, Washington, DC, W1222"},{"key":"276_CR255","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-199920030-00007","volume":"20","author":"O Spigset","year":"1999","unstructured":"Spigset O (1999) Adverse reactions of selective reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf 20:277\u2013287","journal-title":"Drug Saf"},{"key":"276_CR256","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2125.2000.00180.x","volume":"49","author":"G Stacher","year":"2000","unstructured":"Stacher G, Weber U, Stacher-Janotta G, Bauer P, Huber K, Holzapfel A, Krause G, Steinborn C (2000) Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trial. Br J Clin Pharmacol 49:429\u2013436","journal-title":"Br J Clin Pharmacol"},{"key":"276_CR257","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3748\/wjg.v10.i12.1830","volume":"10","author":"YN Sun","year":"2004","unstructured":"Sun YN, Luo JY (2004) Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord. World J Gastroenterol 10:1830\u20131833","journal-title":"World J Gastroenterol"},{"key":"276_CR258","doi-asserted-by":"crossref","first-page":"G838","DOI":"10.1152\/ajpcell.1992.263.4.C838","volume":"263","author":"J Tack","year":"1992","unstructured":"Tack J, Janssens J, Vantrappen G, Wood JD (1992) Actions of 5-hydroxytryptamine on myenteric neurons in guinea pig gastric antrum. Am J Physiol 263:G838\u2013G846","journal-title":"Am J Physiol"},{"key":"276_CR259","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.46.4.468","volume":"46","author":"J Tack","year":"2000","unstructured":"Tack J, Coulie B, Wilmer A, Andrioli A, Janssens J (2000) Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 46:468\u2013473","journal-title":"Gut"},{"key":"276_CR260","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11894-001-0071-y","volume":"3","author":"J Tack","year":"2001","unstructured":"Tack J, Bisschops R, DeMarchi B (2001) Causes and treatment of functional dyspepsia. Curr Gastroenterol Rep 3:503\u2013508","journal-title":"Curr Gastroenterol Rep"},{"key":"276_CR261","doi-asserted-by":"crossref","first-page":"A70","DOI":"10.1053\/j.gastro.2004.01.048","volume":"126","author":"J Tack","year":"2004","unstructured":"Tack J, Van Elzen B, Tytgat G (2004) A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia. Gastroenterology 126:A70","journal-title":"Gastroenterology"},{"key":"276_CR262","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2036.2006.02724.x","volume":"23","author":"J Tack","year":"2006","unstructured":"Tack J, Broekaert D, Corsetti M, Fischler B, Janssens J (2006a) Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man. Aliment Pharmacol Ther 23:265\u2013274","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR263","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1365-2036.2006.02940.x","volume":"23","author":"J Tack","year":"2006","unstructured":"Tack J, Middleton SJ, Horne MC, Piessevaux H, Bloor JS, Meyers NL (2006b) Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther 23:1655\u20131665","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR264","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","volume":"130","author":"J Tack","year":"2006","unstructured":"Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada J-R, Stanghellini V (2006c) Functional gastroduodenal disorders. Gastroenterology 130:1466\u20131479","journal-title":"Gastroenterology"},{"key":"276_CR265","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2982.2006.00839.x","volume":"19","author":"J Tack","year":"2007","unstructured":"Tack J, Vanden Berghe P, Coulie B, Janssens J (2007) Sumatriptan is an agonist at 5-HT receptors on myenteric neurones in the guinea-pig gastric antrum. Neurogastroenterol Motil 19:39\u201346","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR266","first-page":"1151","volume":"272","author":"S Takayanagi","year":"1995","unstructured":"Takayanagi S, Hanai H, Kumagai J, Kaneko E (1995) Serotonin uptake and its modulation in rat jejunal enterocyte preparation. J Pharmacol Exp Ther 272:1151\u20131159","journal-title":"J Pharmacol Exp Ther"},{"key":"276_CR267","first-page":"25","volume":"3","author":"NJ Talley","year":"2003","unstructured":"Talley NJ (2003a) Update on the role of drug therapy in non-ulcer dyspepsia. Rev Gastroenterol Disord 3:25\u201330","journal-title":"Rev Gastroenterol Disord"},{"key":"276_CR268","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1572-0241.2003.07306.x","volume":"98","author":"NJ Talley","year":"2003","unstructured":"Talley NJ (2003b) Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol 98:750\u2013758","journal-title":"Am J Gastroenterol"},{"key":"276_CR269","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1572-0241.2004.04128.x","volume":"99","author":"NJ Talley","year":"2004","unstructured":"Talley NJ (2004) Antidepressants in IBS: are we deluding ourselves? Am J Gastroenterol 99:921\u2013923","journal-title":"Am J Gastroenterol"},{"key":"276_CR270","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1124\/jpet.107.123729","volume":"322","author":"S Tamaoki","year":"2007","unstructured":"Tamaoki S, Yamauchi Y, Nakano Y, Sakano S, Asagarasu A, Sato M (2007) Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model. J Pharmacol Exp Ther 322:1315\u20131323","journal-title":"J Pharmacol Exp Ther"},{"key":"276_CR271","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1476-5381.1994.tb16186.x","volume":"113","author":"FS Tam","year":"1994","unstructured":"Tam FS, Hillier K, Bunce KT (1994) Characterization of the 5-hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colonic circular muscle. Br J Pharmacol 113:143\u2013150","journal-title":"Br J Pharmacol"},{"key":"276_CR272","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0014-2999(96)00312-3","volume":"308","author":"T Tamura","year":"1996","unstructured":"Tamura T, Sano I, Satoh M, Mizumoto A, Itoh Z (1996) Pharmacological characterization of 5-hydroxytryptamine-induced motor activity (in vitro) in the guinea pig gastric antrum and corpus. Eur J Pharmacol 308:315\u2013324","journal-title":"Eur J Pharmacol"},{"key":"276_CR273","first-page":"1098","volume":"258","author":"K Taniyama","year":"1991","unstructured":"Taniyama K, Nakayama S, Takeda K, Matsuyama S, Shirakawa J, Sano I, Tanaka C (1991) Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J Pharmacol Exp Ther 258:1098\u20131104","journal-title":"J Pharmacol Exp Ther"},{"key":"276_CR274","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s005350070056","volume":"35","author":"K Taniyama","year":"2000","unstructured":"Taniyama K, Makimoto N, Furuichi A, Sakurai-Yamashita Y, Nagase Y, Kaibara M, Kanematsu T (2000) Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J Gastroenterol 35:575\u2013582","journal-title":"J Gastroenterol"},{"key":"276_CR275","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2982.2005.00716.x","volume":"17","author":"M Tonini","year":"2005","unstructured":"Tonini M (2005) 5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors. Neurogastroenterol Motil 17:637\u2013642","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR276","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1365-2036.1999.00655.x","volume":"13","author":"M Tonini","year":"1999","unstructured":"Tonini M, De Ponti F, Di Nucci A, Crema F (1999) Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 13:1585\u20131591","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR277","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1053\/j.gastro.2005.08.005","volume":"129","author":"M Tonini","year":"2005","unstructured":"Tonini M, Vicini R, Cervio E, De Ponti F, De Giorgio R, Barbara G, Stanghellini V, Dellabianca A, Sterini C (2005) 5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology 129:1557\u20131566","journal-title":"Gastroenterology"},{"key":"276_CR278","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1471-4159.1994.63020456.x","volume":"63","author":"AP Tsou","year":"1994","unstructured":"Tsou AP, Kosaka A, Bach C, Zuppan P, Yee C, Tom L, Alvarez R, Ramsey S, Bonhaus DW, Stefanich E, Jakeman L, Eglen RM, Chan HW (1994) Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J Neurochem 63:456\u2013464","journal-title":"J Neurochem"},{"key":"276_CR279","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000227054","volume":"49","author":"MB Tyers","year":"2002","unstructured":"Tyers MB, Freeman AJ (2002) Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists. Oncology 49:263\u2013268","journal-title":"Oncology"},{"key":"276_CR280","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.gene.2006.08.002","volume":"386","author":"MV Tzvetkov","year":"2007","unstructured":"Tzvetkov MV, Meineke C, Oetjen E, Hirsch-Ernst K, Brockmoller J (2007) Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine. Gene 386:52\u201362","journal-title":"Gene"},{"key":"276_CR281","first-page":"344","volume":"12","author":"JR Vane","year":"1957","unstructured":"Vane JR (1957) A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol 12:344\u2013349","journal-title":"Br J Pharmacol"},{"key":"276_CR282","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-6147(99)01432-7","volume":"21","author":"P Vanhoenacker","year":"2000","unstructured":"Vanhoenacker P, Haegeman G, Leysen JE (2000) 5-HT7 receptors: current knowledge and future prospect. Trends Pharmacol Sci 21:70\u201377","journal-title":"Trends Pharmacol Sci"},{"key":"276_CR283","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2036.2006.02951.x","volume":"24","author":"N Lelyveld Van","year":"2006","unstructured":"Van Lelyveld N, Ter Linde J, Baron A, Mundt M, Wajs E, Samsom M (2006) The 5-HT4 antagonist R216073 does not affect gastric motor and sensory function in patients with functional dyspepsia. Aliment Pharmacol Ther 24:669\u2013677","journal-title":"Aliment Pharmacol Ther"},{"key":"276_CR284","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2982.2006.00891.x","volume":"19","author":"N Lelyveld Van","year":"2007","unstructured":"Van Lelyveld N, Ter Linde J, Schipper ME, Samsom M (2007) Regional differences in expression of TPH-1, SERT, 5-HT(3) and 5-HT(4) receptors in the human stomach and duodenum. Neurogastroenterol Motil 19:342\u2013348","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR285","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9270(00)02314-5","volume":"96","author":"SJO Veldhuyzen van Zanten","year":"2001","unstructured":"Veldhuyzen van Zanten SJO, Jones MJ, Verlinden M, Talley NJ (2001) Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 96:689\u2013696","journal-title":"Am J Gastroenterol"},{"key":"276_CR286","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0028-3908(01)00154-X","volume":"42","author":"MT Vilaro","year":"2002","unstructured":"Vilaro MT, Domenech T, Palacios JM, Mengod G (2002) Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon. RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants. Neuropharmacology 42:60\u201373","journal-title":"Neuropharmacology"},{"key":"276_CR287","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJM199310073291503","volume":"329","author":"MR Der Ohe Von","year":"1993","unstructured":"Von Der Ohe MR, Camilleri M, Kvols LK, Thomforde GM (1993) Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. New Eng J Med 329:1073\u20131078","journal-title":"New Eng J Med"},{"key":"276_CR288","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1523\/JNEUROSCI.16-07-02352.1996","volume":"16","author":"PR Wade","year":"1996","unstructured":"Wade PR, Chen J, Jaffe B, Kassem IS, Blakely RD, Gershon MD (1996) Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 16:2352\u20132364","journal-title":"J Neurosci"},{"key":"276_CR289","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1476-5381.1993.tb14006.x","volume":"110","author":"KA Wardle","year":"1993","unstructured":"Wardle KA, Sanger GJ (1993) The guinea pig distal colon-a sensitive preparation for the investigation of 5-HT4 receptor-mediated contractions. Br J Pharmacol 110:1593\u20131599","journal-title":"Br J Pharmacol"},{"key":"276_CR290","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.1996.tb15452.x","volume":"118","author":"KA Wardle","year":"1996","unstructured":"Wardle KA, Bingham S, Ellis ES, Gaster LM, Rushant B, Smith MI, Sanger GJ (1996) Selective and functional 5-hydroxytryptamine4 receptor antagonism by SB 207266. Br J Pharmacol 118:665\u2013670","journal-title":"Br J Pharmacol"},{"key":"276_CR291","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1073\/pnas.89.8.3630","volume":"89","author":"RL Weinshank","year":"1992","unstructured":"Weinshank RL, Zgombick JM, Macchi MJ, Branchek TA (1992) Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1Da and 5-HT1Db. Proc Natl Acad Sci USA 89:3630\u20133634","journal-title":"Proc Natl Acad Sci USA"},{"key":"276_CR292","first-page":"59","volume":"3","author":"ML Woolley","year":"2004","unstructured":"Woolley ML, Marsden CA, Fone KC (2004) 5-ht6 receptors. Current Drug Targets 3:59\u201379","journal-title":"Current Drug Targets"},{"issue":"Suppl 2","key":"276_CR293","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2982.2007.00963.x","volume":"19","author":"MM Wouters","year":"2007","unstructured":"Wouters MM, Farrugia G, Schemann M (2007a) 5-HT receptors on interstitial cells of Cajal, smooth muscle and enteric nerves. Neurogastroenterol Motil 19(Suppl 2):5\u201312","journal-title":"Neurogastroenterol Motil"},{"key":"276_CR294","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.gastro.2007.06.017","volume":"133","author":"MM Wouters","year":"2007","unstructured":"Wouters MM, Gibbons SJ, Roeder JL, Distad M, Ou Y, Strege PR, Szurszewski JH, Farrugia G (2007b) Exogenous serotonin regulates proliferation of interstitial cells of Cajal in mouse jejunum through 5-HT2B receptors. Gastroenterology 133:897\u2013906","journal-title":"Gastroenterology"},{"key":"276_CR295","first-page":"G1180","volume":"291","author":"L Xue","year":"2006","unstructured":"Xue L, Camilleri M, Locke GR, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G (2006) Serotonergic modulation of murine fundic tone. Am J Physiol 291:G1180\u2013G1186","journal-title":"Am J Physiol"},{"key":"276_CR296","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/gut.2003.035451","volume":"53","author":"A Yeo","year":"2004","unstructured":"Yeo A, Boyd P, Lumsden S, Saunders T, Handley A, Stubbins M, Knaggs A, Asquith S, Taylor I, Bahari B, Crocker N, Rallan R, Varsani S, Montgomery D, Alpers DH, Dukes GE, Purvis I, Hicks GA (2004) Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 53:1452\u20131458","journal-title":"Gut"},{"key":"276_CR297","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cne.903560107","volume":"356","author":"HM Young","year":"1995","unstructured":"Young HM, Furness JB (1995) Ultrastructural examination of the targets of serotonin-immunoreactive descending reflexes to the circular muscle of guinea pig small intestine. J Comp Neurol 356:101\u2013114","journal-title":"J Comp Neurol"},{"key":"276_CR298","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00003088-200544030-00005","volume":"44","author":"S Zhou","year":"2005","unstructured":"Zhou S, Yung Chan S, Cher Goh B, Chan E, Duan W, Huang M, McLeod HL (2005) Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet 44:279\u2013304","journal-title":"Clin Pharmacokinet"},{"key":"276_CR299","first-page":"566","volume":"15","author":"BF Zuberi","year":"2005","unstructured":"Zuberi BF, Quraishy MS, Faisal N, Ahmed S (2005) Idiopathic gastroparesis. J Coll Physicians Surgeons Pakistan 15:566\u2013577","journal-title":"J Coll Physicians Surgeons Pakistan"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0276-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-008-0276-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0276-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T13:49:43Z","timestamp":1631022583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-008-0276-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,9]]},"references-count":299,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["276"],"URL":"https:\/\/doi.org\/10.1007\/s00210-008-0276-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,9]]}}}